Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 15.04.2025
Pareto Securities AS
Frankfurt, April 15, 2025 – The Nordic high-yield (HY) bond market experienced its most active first quarter on record in Q1 2025. Total issuance reached €7.5 billion – nearly twice the volume of Q1 2024 and already surpassing the full-year figure for 2022. Outstanding volume in the market rose to approximately €65 billion.
Strong refinancing acti [ … ]
Tue, 15.04.2025
Voltabox AG
Voltabox Announces Forecast for Fiscal Year 2025 and Expects Revenue Surge and Positive Earnings Following Strategic Transformation
Paderborn, April 15, 2025 – The Management Board of Voltabox AG (DE000A2E4LE9) today adopted the forecast for the current fiscal year 2025. Following the implementation of key measures for the company’s realignment, t [ … ]
Tue, 15.04.2025
Rhenus
EQS Newswire / 15/04/2025 / 10:00 CET/CEST
SINGAPORE - Media OutReach Newswire - 15 April 2025 - By introducing the new Empowered by You employer brand, the Rhenus Group is taking an important strategic step to further strengthen its corporate culture and promote a sense of belonging among its employees worldwide. A uniform employer brand i [ … ]
Tue, 15.04.2025
Deutsche Rohstoff AG
Additional placement of existing Bond 2023/2028
Deutsche Rohstoff AG is considering increasing its corporate bond
High demand from investors, average bond price at 110% (30 days)
Raised funds would reduce US credit line and increase liquidity for additional opportunities
Strong operating performance, EBITDA of EUR 168 million in 2024
Net debt [ … ]
Tue, 15.04.2025
iOmx Therapeutics AG
iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX‑0675
IOMX‑0675, a LILRB1/LILRB2-dual-targeting antibody, is designed to selectively tune a network of immune-modulatory receptors promoting an immune response to the tumor
Preclinical data demonstrate its best-in-class potential and support its relevance in majo [ … ]
Tue, 15.04.2025
NORMA Group SE
NORMA Group equips British Northern Gas Networks with electrofusion fittings
Maintal, Germany / Nashik, India, April 15, 2025 – NORMA Group is supporting British infrastructure provider Northern Gas Networks in the modernization of its gas distribution system in northern England. Since February 2025, NORMA Group's Indian subsidiary Kimplas Piping [ … ]
Tue, 15.04.2025
More Impact AG
PRESS RELEASE
More Impact AG: Subsidiary BG Braingate Technology receives Notice of Allowance from the US Patent and Trademark Office for innovative technology
Frankfurt am Main, April 15, 2025 – More Impact AG (ISIN: DE000A1PG979, “More Impact”), a listed high-tech medical hub, announces that its subsidiary BG Braingate Technology GmbH (“Brainga [ … ]
Tue, 15.04.2025
LAIQON AG
Company Name:
LAIQON AG
ISIN:
DE000A12UP29
Reason for the research:
Update
Recommendation:
BUY
from:
15.04.2025
Target price:
EUR 7.40
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
FY'24 review: improved cost mix ahead of AuM scalingTo recap: Following preliminary sales and EBITDA figures of M [ … ]
Tue, 15.04.2025
FRIWO AG
FRIWO achieves revised annual targets for 2024 – growth momentum expected from 2025
Group revenue of 93.0 million euros in 2024 within the forecast range
EBIT improved to -3.6 million euros year-on-year
Financial and strategic realignment is being consistently implemented
Positive momentum expected in 2025 – high revenue growth and a sustainable [ … ]
Tue, 15.04.2025
EXASOL AG
Exasol AG: Supervisory Board resolves early extension of CEO Jörg Tewes‘ contract
Nuremberg, 15 April 2025: The Supervisory Board of Exasol AG (ISIN DE000A0LR9G9, Xetra: EXL), a European technology company and provider of a high-performance analytics engine, has early extended the contract of Chief Executive Officer (CEO) Jörg Tewes until 31 Decemb [ … ]